Chronic Obstructive Pulmonary Disease (COPD)
COPD Research Study
Wake Research is comparing two inhaler treatments on patients with Moderate to Severe COPD with cardiovascular disease or risk.
To qualify, you must:
- Be 40-80 years old
- Have Moderate to Severe COPD without an exacerbation within 8 weeks and no history of Asthma lifetime or lung cancer within 5 years
- History of smoking
- No history of Asthma
- No history of Lung Cancer
- Have pre-existing CVD or high-risk CVD conditions (Hypertension, Diabetes, Obesity, etc.)
Qualified participants may receive:
- Study-related medication at no cost
- Study-related medical exams at no cost
- May receive compensation for time
Why Participate?
Contribute to the advancement of medical knowledge and treatments, while receiving expert medical care under close supervision.
Experience
The M3 Wake Research Network has powered innovation with over 9,100 Successful Clinical Trials in patients from 6 months to 85 years.
Safety
Patient safety is paramount with strict protocols and ethical guidelines, minimizing risks and ensuring thorough monitoring throughout the trial.
Wake Research
Study Hotline
+1-919-446-8141
Main Office
+1-919-781-2514
Our Hours
Mon-Fri: 7:30AM to 5PM
Our Location
3100 Duraleigh Rd, Suite 304
Raleigh, NC 27612